{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T08:24:17Z","timestamp":1769588657034,"version":"3.49.0"},"reference-count":47,"publisher":"JLE","issue":"6","license":[{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["N\u00e9phrologie & Th\u00e9rapeutique"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1016\/j.nephro.2017.02.009","type":"journal-article","created":{"date-parts":[[2017,8,24]],"date-time":"2017-08-24T03:05:04Z","timestamp":1503543904000},"page":"470-478","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["La prise en charge des troubles du m\u00e9tabolisme min\u00e9ral et osseux avant le stade de la dialyse reste encore perfectible. \u00c0 partir des donn\u00e9es de l\u2019Observatoire national du m\u00e9tabolisme min\u00e9ral et osseux Photo-Graphe"],"prefix":"10.1684","volume":"13","author":[{"given":"Guillaume","family":"Jean","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c9ric","family":"Daugas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hubert","family":"Roth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0700-7681","authenticated-orcid":false,"given":"Tilman","family":"Drueke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Louis","family":"Bouchet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thierry","family":"Hannedouche","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G\u00e9rard","family":"London","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Denis","family":"Fouque","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"18929","reference":[{"key":"10.1016\/j.nephro.2017.02.009_bib0240","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1681\/ASN.2009121293","article-title":"Forging forward with 10\u00a0burning questions on FGF23\u00a0in kidney disease","volume":"21","author":"Wolf","year":"2010","journal-title":"J Am Soc Nephrol"},{"issue":"4\u00a0Suppl\u00a03","key":"10.1016\/j.nephro.2017.02.009_bib0245","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0272-6386(03)00905-3","article-title":"Bone metabolism and disease in chronic kidney disease","volume":"42","author":"Eknoyan","year":"2003","journal-title":"Am J Kidney Dis"},{"issue":"Suppl.\u00a0113","key":"10.1016\/j.nephro.2017.02.009_bib0250","first-page":"S1","article-title":"Clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone disorder (CKD-MBD)","volume":"76","author":"KDIGO CM","year":"2009","journal-title":"Kidney Int"},{"key":"10.1016\/j.nephro.2017.02.009_bib0255","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1097\/01.ASN.0000133041.27682.A2","article-title":"Mineral metabolism, mortality, and morbidity in maintenance hemodialysis","volume":"15","author":"Block","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.nephro.2017.02.009_bib0260","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1093\/ndt\/gfs404","article-title":"Control of mineral metabolism and bone disease in haemodialysis patients: which optimal targets?","volume":"28","author":"Fouque","year":"2013","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.nephro.2017.02.009_bib0265","doi-asserted-by":"crossref","first-page":"c211","DOI":"10.1159\/000321642","article-title":"Association between very low PTH levels and poor survival rates in haemodialysis patients: results from the French ARNOS cohort","volume":"118","author":"Jean","year":"2011","journal-title":"Nephron Clin Pract"},{"key":"10.1016\/j.nephro.2017.02.009_bib0270","doi-asserted-by":"crossref","first-page":"c204","DOI":"10.1159\/000321507","article-title":"Impact of hypovitaminosis\u00a0D and alfacalcidol therapy on survival of hemodialysis patients: results from the French ARNOS study","volume":"118","author":"Jean","year":"2011","journal-title":"Nephron Clin Pract"},{"key":"10.1016\/j.nephro.2017.02.009_bib0275","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.nephro.2009.09.001","article-title":"[Mineral and bone status in French maintenance hemodialysis patients: a comparison of June 2005\u00a0and June 2008]","volume":"6","author":"Pelletier","year":"2010","journal-title":"Nephrol Ther"},{"issue":"5\u00a0Suppl.\u00a03","key":"10.1016\/j.nephro.2017.02.009_bib0280","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/S0272-6386(04)01103-5","article-title":"Magnitude and impact of abnormal mineral metabolism in hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study (DOPPS)","volume":"44","author":"Young","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.nephro.2017.02.009_bib0285","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1093\/ndt\/gfv099","article-title":"Improvement of mineral and bone metabolism markers is associated with better survival in haemodialysis patients: the COSMOS study","volume":"30","author":"Fernandez-Martin","year":"2015","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.nephro.2017.02.009_bib0290","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/sj.ki.5002009","article-title":"Prevalence of abnormal serum vitamin\u00a0D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease","volume":"71","author":"Levin","year":"2007","journal-title":"Kidney Int"},{"key":"10.1016\/j.nephro.2017.02.009_bib0295","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s40620-015-0202-4","article-title":"Management of CKD-MBD in non-dialysis patients under regular nephrology care: a prospective multicenter study","volume":"29","author":"Gallieni","year":"2016","journal-title":"J Nephrol"},{"key":"10.1016\/j.nephro.2017.02.009_bib0300","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1093\/ndt\/gft388","article-title":"The French Chronic Kidney Disease-Renal Epidemiology and Information Network (CKD-REIN) cohort study","volume":"29","author":"Stengel","year":"2014","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.nephro.2017.02.009_bib0305","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/ki.2009.374","article-title":"Parathyroid hormone measurement in CKD","volume":"77","author":"Souberbielle","year":"2010","journal-title":"Kidney Int"},{"key":"10.1016\/j.nephro.2017.02.009_bib0310","first-page":"2998","article-title":"Effect of creatinine assay standardization on the performance of Cockcroft-Gault and MDRD formula in predicting GFR","volume":"21","author":"Vervoort","year":"2006","journal-title":"Nephrology"},{"key":"10.1016\/j.nephro.2017.02.009_bib0315","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1053\/j.ajkd.2010.06.011","article-title":"Outcomes associated with phosphorus binders in men with non-dialysis-dependent CKD","volume":"56","author":"Kovesdy","year":"2010","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.nephro.2017.02.009_bib0320","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1093\/ndt\/gfl718","article-title":"Mineral metabolism parameters throughout chronic kidney disease stages 1\u20135\u00a0\u2014\u00a0achievement of K\/DOQI target ranges","volume":"22","author":"Craver","year":"2007","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.nephro.2017.02.009_bib0325","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1681\/ASN.2008020159","article-title":"Timing of onset of CKD-related metabolic complications","volume":"20","author":"Moranne","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.nephro.2017.02.009_bib0330","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/sj.ki.5001606","article-title":"Inter-method variability in PTH measurement: implication for the care of CKD patients","volume":"70","author":"Souberbielle","year":"2006","journal-title":"Kidney Int"},{"key":"10.1016\/j.nephro.2017.02.009_bib0335","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1159\/000057611","article-title":"Renal osteodystrophy in predialysis and hemodialysis patients: comparison of histologic patterns and diagnostic predictivity of intact PTH","volume":"91","author":"Coen","year":"2002","journal-title":"Nephron"},{"key":"10.1016\/j.nephro.2017.02.009_bib0340","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s11255-010-9897-2","article-title":"Elevated serum parathyroid hormone is a cardiovascular risk factor in moderate chronic kidney disease","volume":"44","author":"Lishmanov","year":"2012","journal-title":"Int Urol Nephrol"},{"key":"10.1016\/j.nephro.2017.02.009_bib0345","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1038\/ki.2008.64","article-title":"Secondary hyperparathyroidism is associated with higher mortality in men with moderate to severe chronic kidney disease","volume":"73","author":"Kovesdy","year":"2008","journal-title":"Kidney Int"},{"key":"10.1016\/j.nephro.2017.02.009_bib0350","doi-asserted-by":"crossref","first-page":"3037","DOI":"10.1185\/03007990802437943","article-title":"Impact of secondary hyperparathyroidism on disease progression, healthcare resource utilization and costs in pre-dialysis CKD patients","volume":"24","author":"Schumock","year":"2008","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.nephro.2017.02.009_bib0355","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1681\/ASN.2007040449","article-title":"Pitfalls of measuring total blood calcium in patients with CKD","volume":"19","author":"Gauci","year":"2008","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.nephro.2017.02.009_bib0360","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1053\/j.ajkd.2005.05.025","article-title":"Relationship of phosphorus and calcium-phosphorus product with mortality in CKD","volume":"46","author":"Menon","year":"2005","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.nephro.2017.02.009_bib0365","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1681\/ASN.2004070602","article-title":"Serum phosphate levels and mortality risk among people with chronic kidney disease","volume":"16","author":"Kestenbaum","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.nephro.2017.02.009_bib0370","doi-asserted-by":"crossref","first-page":"825","DOI":"10.2215\/CJN.02101205","article-title":"Association of disorders in mineral metabolism with progression of chronic kidney disease","volume":"1","author":"Schwarz","year":"2006","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.nephro.2017.02.009_bib0375","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.2215\/CJN.00260109","article-title":"Vitamin D affects survival independently of vascular calcification in chronic kidney disease","volume":"4","author":"Barreto","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.nephro.2017.02.009_bib0380","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1111\/j.1542-4758.2010.00472.x","article-title":"Prevention of secondary hyperparathyroidism in hemodialysis patients: the key role of native vitamin\u00a0D supplementation","volume":"14","author":"Jean","year":"2010","journal-title":"Hemodial Int"},{"key":"10.1016\/j.nephro.2017.02.009_bib0385","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.clinbiochem.2013.12.026","article-title":"Immune, metabolic and epidemiological aspects of vitamin\u00a0D in chronic kidney disease and transplant patients","volume":"47","author":"Bacchetta","year":"2014","journal-title":"Clin Biochem"},{"key":"10.1016\/j.nephro.2017.02.009_bib0390","doi-asserted-by":"crossref","first-page":"3799","DOI":"10.1093\/ndt\/gfp370","article-title":"Monthly cholecalciferol administration in haemodialysis patients: a simple and efficient strategy for vitamin\u00a0D supplementation","volume":"24","author":"Jean","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.nephro.2017.02.009_bib0395","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1053\/j.ajkd.2005.04.015","article-title":"Vitamin\u00a0D deficiency in CKD: why should we care?","volume":"45","author":"Holick","year":"2005","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.nephro.2017.02.009_bib0400","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1053\/j.ajkd.2007.04.010","article-title":"Changes in serum 25-hydroxyvitamin\u00a0D and plasma intact PTH levels following treatment with ergocalciferol in patients with CKD","volume":"50","author":"Al-Aly","year":"2007","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.nephro.2017.02.009_bib0405","first-page":"193","article-title":"[Comparison of calcium acetate and calcium carbonate for the control of predialysis hyperphosphatemia]","volume":"12","author":"Djerad","year":"1991","journal-title":"Nephrologie"},{"key":"10.1016\/j.nephro.2017.02.009_bib0410","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1093\/ndt\/11.7.1493","article-title":"Low doses of calcitriol or calcium carbonate for the prevention of hyperparathyroidism in predialysis patients?","volume":"11","author":"Fournier","year":"1996","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.nephro.2017.02.009_bib0415","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1681\/ASN.2012030223","article-title":"Effects of phosphate binders in moderate CKD","volume":"23","author":"Block","year":"2012","journal-title":"J Am Soc Nephrol"},{"issue":"Suppl.\u00a03","key":"10.1016\/j.nephro.2017.02.009_bib0420","first-page":"67","article-title":"[Changes in mineral metabolism in stage\u00a03, 4, and\u00a05\u00a0chronic kidney disease (not on dialysis)]","volume":"28","author":"Lorenzo Sellares","year":"2008","journal-title":"Nefrologia"},{"key":"10.1016\/j.nephro.2017.02.009_bib0425","first-page":"129","article-title":"1-alpha-OH-cholecalciferol (1-alpha-OHD3) and low phosphate diet in predialysis chronic renal failure: effects on renal function and on secondary hyperparathyroidism","volume":"6","author":"Coen","year":"1984","journal-title":"Acta Vitaminol Enzymol"},{"key":"10.1016\/j.nephro.2017.02.009_bib0430","first-page":"375","article-title":"Treatment of secondary hyperparathyroidism of predialysis chronic renal failure with low doses of 1,25(OH)2D3: humoral and histomorphometric results","volume":"12","author":"Coen","year":"1986","journal-title":"Miner Electrolyte Metab"},{"key":"10.1016\/j.nephro.2017.02.009_bib0435","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1210\/jcem-67-5-929","article-title":"Low dose calcitriol versus placebo in patients with predialysis chronic renal failure","volume":"67","author":"Nordal","year":"1988","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.nephro.2017.02.009_bib0440","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1017\/S1751731108003200","article-title":"Nutritional properties of potato protein concentrate compared with soybean meal as the main protein source in feed for the double-muscled Belgian Blue bull","volume":"3","author":"Froidmont","year":"2009","journal-title":"Animal"},{"key":"10.1016\/j.nephro.2017.02.009_bib0445","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1159\/000188515","article-title":"Bone mineral density evaluated by dual-energy X-ray absorptiometry after one-year treatment with calcitriol started in the predialysis phase of chronic renal failure","volume":"69","author":"Przedlacki","year":"1995","journal-title":"Nephron"},{"key":"10.1016\/j.nephro.2017.02.009_bib0450","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1007\/s00774-006-0730-z","article-title":"Annual change in bone mineral density in predialysis patients with chronic renal failure: significance of a decrease in serum 1,25-dihydroxy-vitamin\u00a0D","volume":"25","author":"Obatake","year":"2007","journal-title":"J Bone Min Metab"},{"key":"10.1016\/j.nephro.2017.02.009_bib0455","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1053\/j.ajkd.2005.04.013","article-title":"Cinacalcet hydrochloride is an effective treatment for secondary hyperparathyroidism in patients with CKD not receiving dialysis","volume":"46","author":"Charytan","year":"2005","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.nephro.2017.02.009_bib0460","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1046\/j.1523-1755.2002.00434.x","article-title":"Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients","volume":"62","author":"Chertow","year":"2002","journal-title":"Kidney Int"},{"key":"10.1016\/j.nephro.2017.02.009_bib0465","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1097\/01.ASN.0000129337.50739.48","article-title":"Arterial calcifications and bone histomorphometry in end-stage renal disease","volume":"15","author":"London","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.nephro.2017.02.009_bib0235","doi-asserted-by":"crossref","first-page":"F253","DOI":"10.1152\/ajprenal.00302.2004","article-title":"The calcium-sensing receptor: a key factor in the pathogenesis of secondary hyperparathyroidism","volume":"288","author":"Rodriguez","year":"2005","journal-title":"Am J Physiol Renal Physiol"}],"container-title":["N\u00e9phrologie & Th\u00e9rapeutique"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1769725517301621?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1769725517301621?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.jle.com\/10.1016\/j.nephro.2017.02.009","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T16:45:22Z","timestamp":1741193122000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1769725517301621"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":47,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,11]]}},"alternative-id":["S1769725517301621"],"URL":"https:\/\/doi.org\/10.1016\/j.nephro.2017.02.009","relation":{},"ISSN":["1769-7255"],"issn-type":[{"value":"1769-7255","type":"print"}],"subject":[],"published":{"date-parts":[[2017,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"La prise en charge des troubles du m\u00e9tabolisme min\u00e9ral et osseux avant le stade de la dialyse reste encore perfectible. \u00c0 partir des donn\u00e9es de l\u2019Observatoire national du m\u00e9tabolisme min\u00e9ral et osseux Photo-Graphe","name":"articletitle","label":"Article Title"},{"value":"N\u00e9phrologie & Th\u00e9rapeutique","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nephro.2017.02.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Published by Elsevier Masson SAS on behalf of Soci\u00e9t\u00e9 francophone de n\u00e9phrologie, dialyse et transplantation.","name":"copyright","label":"Copyright"}]}}